Corrigendum to "N-acetylneuraminic acid and chondroitin sulfate modified nanomicelles with ROS-sensitive H2S donor via targeting E-selectin receptor and CD44 receptor for the efficient therapy of atherosclerosis" [Int. J. Biol. Macromol. Vol. 211 Page 259-270]
Int J Biol Macromol. 2024 May 17;270(Pt 1):132202.
doi: 10.1016/j.ijbiomac.2024.132202.
Online ahead of print.
1 Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs, School of Pharmacy, Yantai University, Yantai 264005, PR China.
2 Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs, School of Pharmacy, Yantai University, Yantai 264005, PR China; College of Marine Life Science, Ocean University of China, Qingdao 266003, PR China.
3 Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs, School of Pharmacy, Yantai University, Yantai 264005, PR China. Electronic address: cdq1981@126.com.